Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-062697

Neos Therapeutics, Inc. · NEOS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jul 27, 2015
Accepted (ET)
Jul 28, 2015 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467652

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 28, 2015C406,250—A406,250D
Common StockF1Jul 28, 2015C677,622—A1,083,872D
Common StockF2Jul 28, 2015C162,500—A1,246,372D
Common StockF1Jul 28, 2015C10,416—A1,256,788Iby Presidio Partners 2007 (Parallel), L.P
Common StockF1Jul 28, 2015C17,374—A1,274,162Iby Presidio Partners 2007 (Parallel), L.P
Common StockF2Jul 28, 2015C4,166—A1,278,328Iby Presidio Partners 2007 (Parallel), L.P

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Preferred StockF1—Jul 28, 2015C975,000D——Common Stock406,2500D
Series C Preferred StockF1—Jul 28, 2015C1,626,294D——Common Stock677,6220D
Preferred Stock Warrant (Right to Buy)F3,F1—Jul 27, 2015X390,000D—Jan 30, 2018Series C Preferred Stock390,0000D
Series C Preferred StockF1—Jul 28, 2015C390,000D——Common Stock162,5000D
Series B Preferred StockF1—Jul 28, 2015C25,000D——Common Stock10,4160I
Series C Preferred StockF1—Jul 28, 2015C41,700D——Common Stock17,3740I
Preferred Stock Warrant (Right to Buy)F3—Jul 27, 2015X10,000D—Jan 30, 2018Series C Preferred Stock10,0000I
Series C Preferred StockF1—Jul 28, 2015C10,000D——Common Stock4,1660I

Explanation of responses